NOVARTIS AG's Net Worth

$1.34 Billion

Estimate Recalculated Feb 26, 2024 04:07PM EST

Who is NOVARTIS AG?

NOVARTIS AG has an estimated net worth of $1.34 Billion. This is based on reported shares across multiple companies, which include Cellular Biomedicine Group, Inc., Poseida Therapeutics, Inc., Akouos, Inc., Forma Therapeutics Holdings, Inc.,, Galera Therapeutics, Inc., BICYCLE THERAPEUTICS plc, AveXis, Inc., Surface Oncology, Inc., Homology Medicines, Inc., Intellia Therapeutics, Inc., AILERON THERAPEUTICS INC, Altimmune, Inc., Aerpio Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., Aeglea BioTherapeutics, Inc., PROTEOSTASIS THERAPEUTICS, INC., Tokai Pharmaceuticals Inc, Marina Biotech, Inc., MOMENTA PHARMACEUTICALS INC, ALNYLAM PHARMACEUTICALS, INC., EON LABS INC, IDENIX PHARMACEUTICALS INC, CHIRON CORP, and PRECISION BIOSCIENCES INC.

SEC CIK

NOVARTIS AG's CIK is 0001114448

Past Insider Trading and Trends

2012 was NOVARTIS AG's most active year for acquiring shares with 19 total transactions. NOVARTIS AG's most active month to acquire stocks was the month of January. 2011 was NOVARTIS AG's most active year for disposing of shares, totalling 79 transactions. NOVARTIS AG's most active month to dispose stocks was the month of December. 2005 saw NOVARTIS AG paying a total of $405,141,038.65 for 12,022,776 shares, this is the most they've acquired in one year. In 2014 NOVARTIS AG cashed out on 78,558,820 shares for a total of $816,566,346.40, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cellular Biomedicine Group, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Poseida Therapeutics, Inc. (PSTX) Snapshot price: $3.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
5.91M
5.91M
Jul 14
Form 3
0
0
No matching records found

Akouos, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.18M
$17.00
1.18M
Jun 30
Form 3
0
0
No matching records found

Forma Therapeutics Holdings, Inc., No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1729

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-28.88%
-1.00M
$8.25
-$8,268,960.00
2.47M
Jun 18 - Jun 19
Form 4
-0.56%
-19.39K
$9.21
-$178,610.14
3.47M
Jun 15 - Jun 17
Form 4
-0.49%
-17.23K
$9.33
-$160,809.72
3.49M
Jun 10 - Jun 12
Form 4
-0.60%
-21.31K
$9.57
-$203,904.26
3.51M
Jun 5 - Jun 9
Form 4
-0.42%
-14.96K
$9.68
-$144,850.56
3.53M
Jun 2 - Jun 4
Form 4
3.54M
$12.00
3.54M
Nov 12
Form 3
0
0
No matching records found